@dr_yakupergun : Final results of RIGHT Choice: Ribociclib plus ET vs ChT in premenopausal women with clinically aggressive HR+/HER2− aBC 🔍47.7% patients had investigator-assessed visceral crisis R+ET vs ChT mPFS➡️21.8 vs 12.8 mo ORR➡️66.1% vs 61.8% @OncoAlert ascopubs.org/doi/150.1200/JC… • TwiCopy

Yakup Ergün

@dr_yakupergun

+ Follow

Medical Oncologist / Bower Hospital /
Exploring Evidence-Based Approaches in Cancer | #bcsm #crcsm #lcsm #cancer

ID: 1008888613

calendar_today13-12-2012 13:59:18

1,1K Tweet

3,3K Takipçi

330 Takip Edilen

Yakup Ergün

@dr_yakupergun

4 months ago

Final results of RIGHT Choice: Ribociclib plus ET vs ChT in premenopausal women with clinically aggressive HR+/HER2− aBC 🔍47.7% patients had investigator-assessed visceral crisis R+ET vs ChT mPFS➡️21.8 vs 12.8 mo ORR➡️66.1% vs 61.8% OncoAlert ascopubs.org/doi/10.1200/JC…